García-Velasco J A, Zúñiga A, Pacheco A, Gómez R, Simón C, Remohí J, Pellicer A
IVI-Madrid, Rey Juan Carlos University, Spain.
Hum Reprod. 2004 Jul;19(7):1530-8. doi: 10.1093/humrep/deh298. Epub 2004 May 20.
This study was conducted to investigate the mechanisms by which coasting may be effective in decreasing the incidence of ovarian hyperstimulation syndrome (OHSS).
A total of 160 women (patients and oocyte donors) undergoing coasting and 116 controls were included in the study. Serum, follicular fluid and granulosa cells were collected on the day of oocyte retrieval. Vascular endothelial growth factor (VEGF) concentrations were determined using an enzyme-linked immunosorbent assay (ELISA). Real-time PCR was performed to evaluate VEGF gene expression in granulosa cells. Cell death was studied by flow cytometry using annexin V-fluorescein isothiocyanate (FITC) and counterstaining by propidium iodide, and double staining with CD45 monoclonal antibody was performed to distinguish the contamination of apoptotic leukocytes.
Follicular cells aspirated from coasted patients showed a ratio in favour of apoptosis, especially in smaller follicles (48 versus 26%, P < 0.05). Follicular fluid determinations confirmed that coasting reduces VEGF protein secretion (1413 versus 3538 pg/ml, P < 0.001) and gene expression (2-fold decrease) in granulosa cells. Follicular fluid VEGF protein levels positively correlated with follicular size (r = 0.594, P = 0.001) and estradiol production (r = 0.558, P = 0.038). Women who underwent coasting showed a comparable IVF cycle outcome; however, a higher cancellation rate was found in cycles that were coasted.
Coasting affects all follicles through apoptosis, especially immature follicles, without affecting oocyte/endometrial quality. The significant decrease found in VEGF expression and secretion explains why coasting is clinically effective in reducing the incidence and severity of OHSS.
本研究旨在探讨卵泡期停用促性腺激素在降低卵巢过度刺激综合征(OHSS)发生率方面可能有效的机制。
本研究共纳入160名接受卵泡期停用促性腺激素的女性(患者和卵母细胞捐赠者)及116名对照者。在取卵日收集血清、卵泡液和颗粒细胞。采用酶联免疫吸附测定(ELISA)法测定血管内皮生长因子(VEGF)浓度。进行实时聚合酶链反应(PCR)以评估颗粒细胞中VEGF基因表达。采用膜联蛋白V-异硫氰酸荧光素(FITC)通过流式细胞术研究细胞死亡情况,并用碘化丙啶进行复染,同时用CD45单克隆抗体进行双重染色以区分凋亡白细胞的污染情况。
从接受卵泡期停用促性腺激素的患者中吸出的卵泡细胞显示出凋亡倾向,尤其是在较小的卵泡中(48%对26%,P<0.05)。卵泡液检测证实,卵泡期停用促性腺激素可降低颗粒细胞中VEGF蛋白分泌(1413对3538 pg/ml,P<0.001)和基因表达(降低2倍)。卵泡液VEGF蛋白水平与卵泡大小(r = 0.594,P = 0.001)和雌二醇产生量(r = 0.558,P = 0.038)呈正相关。接受卵泡期停用促性腺激素的女性显示出可比的体外受精周期结局;然而,在进行卵泡期停用促性腺激素的周期中发现取消率较高。
卵泡期停用促性腺激素通过凋亡影响所有卵泡,尤其是未成熟卵泡,而不影响卵母细胞/子宫内膜质量。VEGF表达和分泌的显著降低解释了为什么卵泡期停用促性腺激素在临床上可有效降低OHSS的发生率和严重程度。